Forte Biosciences (FBRX) IV bid into data

Forte Biosciences (NASDAQ: FBRX) August call option implied volatility is at 230, September is at 275; compared to its 52-week range of 87 to 265 into the expected release of FB-401 Phase 2 data in Atopic Dermatitis.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Northrop Grumman (NOC) call put ratio 1 call to 1.6 puts as share price up 3%
• RH (RH) call put ratio 1 call to 2.2 puts into quarter results